Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Running, not enrolling · Phase 4

Conditions studied: Peyronie's Disease

In brief

The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

Key facts

Study ID

NCT04786106

Run by

Charitable Union for the Research and Education of Peyronie's Disease

People needed

40

Starts

2020-12-30

Expected to finish

2027-02-15

Last updated by the study team

2025-02-13

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Men with PD
• >18 years old
• Curvature ≥30 degrees
• Ability to achieve an erection satisfactory for intercourse with or without PDE5 inhibitors

You may not qualify if…

• Prior treatment with CCH or surgery
• Moderate (shadowing) or severe (>1 cm) penile calcification
• Any contraindications to CCH, PTT, or surgery - as determined by the PI

Where it is running

• The Male Fertility and Peyronie's Clinic — Orem, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.